---
authors:
- Foster, Stephen R
- Liddell, Kodi M
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/39823627/
file_path: 2025/01/gepirone-exxua-for-the-treatment-of-major-depressive-disorde.md
issue: '1'
last_updated: '2025-07-30'
original_format: PubMed
pages: 87-88
patient_population: Adults
peer_reviewed: true
pmid: '39823627'
processed_date: '2025-07-30'
publication_date: '2025-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Gepirone (Exxua) for the Treatment of Major Depressive Disorder.
topics:
- Family Medicine
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '39823627'
  title: Gepirone (Exxua) for the Treatment of Major Depressive Disorder.
  authors:
  - last_name: Foster
    fore_name: Stephen R
    initials: SR
    affiliation: University of Arkansas for Medical Sciences, Little Rock.
  - last_name: Liddell
    fore_name: Kodi M
    initials: KM
    affiliation: University of Arkansas for Medical Sciences, Little Rock.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '1'
  publication_info:
    year: '2025'
    month: '01'
    full_date: '2025-01-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '39823627'
  title: Gepirone (Exxua) for the Treatment of Major Depressive Disorder.
  authors:
  - name: Foster SR
    authtype: Author
    clusterid: ''
  - name: Liddell KM
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Jan
- pmid: '39493804'
  title: 'Gepirone: A New Extended-Release Oral Selective Serotonin Receptor Agonist
    for Major Depressive Disorder.'
  authors:
  - name: Phillips B
    authtype: Author
    clusterid: ''
  - name: O'Connor C
    authtype: Author
    clusterid: ''
  - name: St Onge E
    authtype: Author
    clusterid: ''
  source: J Pharm Technol
  pubdate: 2024 Oct
- pmid: '38905523'
  title: Gepirone (Exxua) for depression.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2024 Jun 24
- pmid: '12716264'
  title: 'Gepirone extended-release: new evidence for efficacy in the treatment of
    major depressive disorder.'
  authors:
  - name: Feiger AD
    authtype: Author
    clusterid: ''
  - name: Heiser JF
    authtype: Author
    clusterid: ''
  - name: Shrivastava RK
    authtype: Author
    clusterid: ''
  - name: Weiss KJ
    authtype: Author
    clusterid: ''
  - name: Smith WT
    authtype: Author
    clusterid: ''
  - name: Sitsen JM
    authtype: Author
    clusterid: ''
  - name: Gibertini M
    authtype: Author
    clusterid: ''
  source: J Clin Psychiatry
  pubdate: 2003 Mar
- pmid: '38993656'
  title: The Black Book of Psychotropic Dosing and Monitoring.
  authors:
  - name: DeBattista C
    authtype: Author
    clusterid: ''
  - name: Schatzberg AF
    authtype: Author
    clusterid: ''
  source: Psychopharmacol Bull
  pubdate: 2024 Jul 8
---

# Gepirone (Exxua) for the Treatment of Major Depressive Disorder.

**Authors:** Foster, Stephen R, Liddell, Kodi M

**Published in:** American family physician | Vol. 111, No. 1 | 2025-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/39823627/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/39823627/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
